Tellgen Corp (300642) - Net Assets

Latest as of March 2026: CN¥1.47 Billion CNY ≈ $215.80 Million USD

Based on the latest financial reports, Tellgen Corp (300642) has net assets worth CN¥1.47 Billion CNY (≈ $215.80 Million USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥2.01 Billion ≈ $294.79 Million USD) and total liabilities (CN¥539.79 Million ≈ $78.99 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check tangible equity quality of Tellgen Corp to evaluate the tangible quality of the company's equity base.

Key Net Assets Metrics

Metric	Value
Current Net Assets	CN¥1.47 Billion
% of Total Assets	73.21%
Annual Growth Rate	26.12%
5-Year Change	6.03%
10-Year Change	412.88%
Growth Volatility	53.93

Tellgen Corp - Net Assets Trend (2012–2025)

This chart illustrates how Tellgen Corp's net assets have evolved over time, based on quarterly financial data. See Tellgen Corp defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.

Annual Net Assets for Tellgen Corp (2012–2025)

The table below shows the annual net assets of Tellgen Corp from 2012 to 2025. For live valuation and market cap data, see how much is Tellgen Corp worth.

Year	Net Assets	Change
2025-12-31	CN¥1.48 Billion ≈ $216.63 Million	-2.48%
2024-12-31	CN¥1.52 Billion ≈ $222.14 Million	-1.15%
2023-12-31	CN¥1.54 Billion ≈ $224.72 Million	+3.72%
2022-12-31	CN¥1.48 Billion ≈ $216.67 Million	+6.04%
2021-12-31	CN¥1.40 Billion ≈ $204.32 Million	+10.24%
2020-12-31	CN¥1.27 Billion ≈ $185.34 Million	+8.38%
2019-12-31	CN¥1.17 Billion ≈ $171.01 Million	+14.11%
2018-12-31	CN¥1.02 Billion ≈ $149.87 Million	+14.32%
2017-12-31	CN¥895.86 Million ≈ $131.09 Million	+210.36%
2016-12-31	CN¥288.65 Million ≈ $42.24 Million	+50.09%
2015-12-31	CN¥192.33 Million ≈ $28.14 Million	+46.76%
2014-12-31	CN¥131.05 Million ≈ $19.18 Million	+37.88%
2013-12-31	CN¥95.04 Million ≈ $13.91 Million	+31.15%
2012-12-31	CN¥72.47 Million ≈ $10.60 Million	--

Equity Component Analysis

This analysis shows how different components contribute to Tellgen Corp's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have grown by 15897.9% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2025)

Component	Amount	Percentage
Retained Earnings	CN¥787.13 Million	55.18%
Other Components	CN¥639.28 Million	44.82%
Total Equity	CN¥1.43 Billion	100.00%

Tellgen Corp Competitors by Market Cap

The table below lists competitors of Tellgen Corp ranked by their market capitalization.

Company	Market Cap
Cotec Construction JSC VN:CTD	$297.82 Million
DYNAGREEN EN.PR.GR.H YC 1 F:DYN	$297.83 Million
Bleichroeder Acquisition Corp. II Class A Ordinary Shares NASDAQ:BBCQ	$297.85 Million
Text S.A. WAR:TXT	$298.07 Million
Hutchison Telecommunications (Australia) Ltd AU:HTA	$297.71 Million
Giantplus Technology Co Ltd TW:8105	$297.70 Million
Zhubo Design SHE:300564	$297.67 Million
Bintang Oto Global Tbk PT JK:BOGA	$297.53 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Tellgen Corp's equity between the two most recent reporting periods.

Equity Growth Insights

From 2024 to 2025, total equity changed from 1,507,493,000 to 1,426,405,237, a change of -81,087,763 (-5.4%).
Net income of 3,587,909 contributed positively to equity growth.
Dividend payments of 28,835,494 reduced retained earnings.
Other factors decreased equity by 55,840,178.

Equity Change Factors (2024 to 2025)

Factor	Impact	Contribution
Net Income	CN¥3.59 Million	+0.25%
Dividends Paid	CN¥28.84 Million	-2.02%
Other Changes	CN¥-55.84 Million	-3.91%
Total Change	CN¥-	-5.38%

Book Value vs Market Value Analysis

This analysis compares Tellgen Corp's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 1.43x
The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
The price-to-book ratio has decreased from 20.99x to 1.43x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2012-12-31	CN¥0.60	CN¥12.52	x
2013-12-31	CN¥0.78	CN¥12.52	x
2014-12-31	CN¥1.08	CN¥12.52	x
2015-12-31	CN¥1.58	CN¥12.52	x
2016-12-31	CN¥2.37	CN¥12.52	x
2017-12-31	CN¥6.03	CN¥12.52	x
2018-12-31	CN¥6.31	CN¥12.52	x
2019-12-31	CN¥7.19	CN¥12.52	x
2020-12-31	CN¥7.77	CN¥12.52	x
2021-12-31	CN¥8.48	CN¥12.52	x
2022-12-31	CN¥9.05	CN¥12.52	x
2023-12-31	CN¥9.37	CN¥12.52	x
2024-12-31	CN¥9.30	CN¥12.52	x
2025-12-31	CN¥8.78	CN¥12.52	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Tellgen Corp utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): 0.25%
The company may be facing challenges in efficiently utilizing shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: 0.99%
• Asset Turnover: 0.18x
• Equity Multiplier: 1.44x
Recent ROE (0.25%) is below the historical average (15.53%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2012	18.79%	27.96%	0.60x	1.12x	CN¥6.37 Million
2013	23.75%	29.39%	0.60x	1.35x	CN¥13.07 Million
2014	27.47%	30.46%	0.73x	1.23x	CN¥22.90 Million
2015	34.20%	38.83%	0.73x	1.20x	CN¥46.55 Million
2016	33.87%	42.28%	0.68x	1.18x	CN¥68.90 Million
2017	14.16%	41.87%	0.32x	1.04x	CN¥37.23 Million
2018	13.83%	38.84%	0.33x	1.08x	CN¥39.28 Million
2019	13.44%	35.57%	0.35x	1.07x	CN¥40.15 Million
2020	9.52%	24.62%	0.36x	1.08x	CN¥-6.11 Million
2021	11.56%	24.61%	0.44x	1.08x	CN¥21.70 Million
2022	8.47%	17.42%	0.43x	1.13x	CN¥-22.48 Million
2023	5.85%	16.47%	0.32x	1.10x	CN¥-63.45 Million
2024	2.29%	7.91%	0.25x	1.16x	CN¥-116.21 Million
2025	0.25%	0.99%	0.18x	1.44x	CN¥-139.05 Million

Industry Comparison

This section compares Tellgen Corp's net assets metrics with peer companies in the Medical Devices industry.

Industry Context

Industry: Medical Devices
Average net assets among peers: $1,869,358,268
Average return on equity (ROE) among peers: 12.87%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
Tellgen Corp (300642)	CN¥1.47 Billion	18.79%	0.37x	$297.79 Million
Shanghai Kehua Bio-Engineering Co Ltd (002022)	$1.03 Billion	22.10%	0.17x	$369.55 Million
Jiangsu Yuyue Medical Equipment & Supply Co Ltd (002223)	$482.51 Million	20.84%	0.32x	$3.70 Billion
Double Medical Technology Inc (002901)	$2.13 Billion	28.38%	0.24x	$2.52 Billion
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A (002932)	$242.93 Million	26.96%	0.06x	$505.95 Million
Lepu Medical Tech Beijing (300003)	$8.00 Billion	21.55%	0.99x	$3.16 Billion
INKON Life Technology Co Ltd (300143)	$1.37 Billion	-51.44%	0.43x	$761.10 Million
Edan Instruments Inc (300206)	$1.22 Billion	8.49%	0.19x	$1.15 Billion
Guangdong Biolight Meditech Co Ltd (300246)	$992.38 Million	6.43%	0.73x	$717.10 Million
Beijing Leadman Biochemistry Co Ltd (300289)	$83.90 Million	31.18%	0.36x	$466.49 Million
Sinocare Inc (300298)	$3.14 Billion	14.20%	0.47x	$1.19 Billion

About Tellgen Corp

SHE:300642 China Medical Devices

Market Cap

$297.79 Million

CN¥2.04 Billion CNY

Market Cap Rank

#14974 Global

#4439 in China

Share Price

CN¥12.52

Change (1 day)

-3.10%

52-Week Range

CN¥12.52 - CN¥31.30

All Time High

CN¥46.24